Academic Rank:
Associate Professor, UBC

Short Bio:

Dr. Scott’s lab focuses on discovery and development of clinically relevant biomarkers to improve disease classification and patient care. Dr. Scott is a member of the Lymphoma/Leukemia Molecular Profiling Project Consortium and is leading a large international project along with distinguished lymphoma clinicians and experts in Cancer Genomics to uncover lymphoma pathogenesis and genomic mechanisms underlying treatment failure in aggressive lymphoma. Also, Dr. Scott is co-leading a large scale applied research project funded by Genome Canada, Genome BC, Canadian Institutes of Health Research and BC Cancer Foundation to address the most significant knowledge gap in lymphoma care; the genome biology of relapsed lymphoid cancers. Dr. Scott has a strong track record of discovery of biomarkers applicable to aggressive B-cell lymphomas and is recognized as an expert in biomarkers and the tumor microenvironment of these diseases. Dr. Scott has developed prognostic and predictive biomarker assays and filed four patents to date, which reflects the true translational nature of his research.